MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercise of
warrants
$1,942K
Net cash provided by
(used in) financing...
$1,144K
Canceled cashflow
$798K
Net increase
(decrease) in cash and cash...
-$34,920K
Canceled cashflow
$1,144K
Stock-based compensation
$1,362K
Accounts payable
$1,089K
Operating lease
right-of-use asset
$283K
Depreciation
$90K
Proceeds from maturity
and redemption of...
$29,136K
Offering costs paid in
connection with public...
$526K
Taxes paid related to
net share...
$272K
Net cash provided by
(used in) operating...
-$21,343K
Net cash provided by
(used in) investing...
-$14,721K
Canceled cashflow
$2,824K
Canceled cashflow
$29,136K
Net income (loss)
-$17,782K
Other assets
$3,030K
Accrued expenses and
other current...
-$2,602K
Purchase of marketable
debt securities
$43,857K
Operating lease
liabilities
-$302K
Prepaid expenses and
other current assets
$261K
Amortization of premium
(accretion of discount) on...
-$190K
Back
Back
Cash Flow
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)
source: myfinsight.com